BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
1.320
-0.030 (-2.22%)
At close: Jul 2, 2024, 4:00 PM
1.360
+0.040 (3.03%)
After-hours: Jul 2, 2024, 7:25 PM EDT
BioAtla Stock Forecast
BCAB's stock price has decreased by -55.1% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for BioAtla stock have an average target of 12.75, with a low estimate of 5.00 and a high estimate of 25. The average target predicts an increase of 865.91% from the current stock price of 1.32.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 23, 2024.
Analyst Ratings
The average analyst rating for BioAtla stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Maintains $12 → $5 | Buy | Maintains | $12 → $5 | +278.79% | May 23, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +430.30% | May 15, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +809.09% | Mar 28, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +430.30% | Mar 27, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +809.09% | Dec 5, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.65
from -2.58
EPS Next Year
-1.51
from -1.65
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 20.7M | 69.0M | 150.2M |
Avg | n/a | n/a | 10.0M | 33.7M | 114.8M |
Low | n/a | n/a | n/a | 14.5M | 91.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 586.6% | 345.5% |
Avg | - | - | - | 235.5% | 240.6% |
Low | - | - | - | 44.4% | 171.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.58 | -1.08 | -1.46 | -1.21 | -0.02 |
Avg | -1.65 | -1.51 | -1.65 | -1.21 | -0.36 |
Low | -1.75 | -1.71 | -1.80 | -1.20 | -0.68 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.